RYTM
Rhythm Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $6.58B | Price | $113.76 |
| Volume | 833.25K | Change | +1.74% |
| P/E Ratio | -25.2 | Open | $110.77 |
| Revenue | $130.1M | Prev Close | $111.81 |
| Net Income | $-260.6M | 52W Range | $45.91 - $116.00 |
| Div Yield | N/A | Target | $118.00 |
| Overall | 65 | Value | 40 |
| Quality | -- | Technical | 91 |
No chart data available
Stock Overview
Updated DailyRhythm Pharmaceuticals Inc. (RYTM) is a leading diversified company in the Biotechnology industry, currently trading at $113.76 with a market capitalization of $6.58 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows RYTM with a volume of 833K shares. The stock opened down 0.93% from yesterday's close of $111.81. Current analyst estimates project earnings of $-2.96 per share for this year, with next year targeting $-2.02.
RYTM demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for RYTM include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 3.7%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 04:49 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RYTM | $113.76 | +1.7% | 833.25K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rhythm Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW